How much is Mythic Therapeutics worth in 2026?

Mythic Therapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Mythic Therapeutics raised?

Mythic Therapeutics has raised $156.5M in total funding across 1 funding rounds.

Mythic Therapeutics

Drug DiscoveryWebsite

Mythic Therapeutics valuation and funding history | Last updated: December 24, 2024 | 1 funding rounds

Current Valuation

N/A

As of December 24, 2024

Total Funding Raised

$156.5M

Across 1 round

Last Round

Later Stage VC

$29.9M

Last Funding

Dec 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 15, 2021	Early Stage VC (Series B)	$103.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Mythic Therapeutics is currently valued at N/A as of December 24, 2024. The company has raised a total of $156.5M in funding across 1 funding round.

Track Mythic Therapeutics Valuation Updates

Get notified when Mythic Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Mythic Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Mythic Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Mythic Therapeutics Worth in 2026?

Mythic Therapeutics is a leading private company in the Drug Discovery sector. Track Mythic Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Mythic Therapeutics Valuation is Determined

Private company valuations like Mythic Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.